Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Huober, Jens; Weder, Patrik; Ribi, Karin; Thürlimann, Beat; Thery, Jean-Christophe; Li, Qiyu; Vanlemmens, Laurence; Guiu, Séverine; Brain, Etienne; Grenier, Julien; Dalenc, Florence; Levy, Christelle; Savoye, Aude-Marie; Müller, Andreas; Membrez-Antonioli, Véronique; Gérard, Marie-Aline; Lemonnier, Jérôme; Hawle, Hanne; Dietrich, Daniel; Boven, Epie; Bonnefoi, Hervé

Huober, Jens; Weder, Patrik; Ribi, Karin; Thürlimann, Beat; Thery, Jean-Christophe; Li, Qiyu; Vanlemmens, Laurence; Guiu, Séverine; Brain, Etienne; Grenier, Julien; Dalenc, Florence; Levy, Christelle; Savoye, Aude-Marie; Müller, Andreas; Membrez-Antonioli, Véronique; Gérard, Marie-Aline; Lemonnier, Jérôme; Hawle, Hanne; Dietrich, Daniel; Boven, Epie; Bonnefoi, Hervé.

Afiliación

Huober J; Breast Center St Gallen, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Weder P; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.
Ribi K; Breast Center St Gallen, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Thürlimann B; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.
Thery JC; Quality of Life Office, International Breast Cancer Study Group, Bern, Switzerland.
Li Q; Breast Center St Gallen, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Vanlemmens L; Department of Medical Oncology, Center Henri Becquerel, Rouen, France.
Guiu S; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.
Brain E; Department of Medical Oncology, Center Oscar Lambret, Lille, France.
Grenier J; Department of Medical Oncology, Regional Cancer Institute, Montpellier, France.
Dalenc F; Department of Medical Oncology, Institute Curie, Paris & Saint-Cloud, France.
Levy C; Department of Medical Oncology, Institute Sainte Catherine, Avignon, France.
Savoye AM; Department of Medical Oncology, Institute Claudius Regaud-Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Müller A; Department of Medical Oncology, Center Francois Baclesse, Caen, France.
Membrez-Antonioli V; Department of Medical Oncology, Institute Jean Godinot, Reims, France.
Gérard MA; Breast Center, Cantonal Hospital of Winterthur, Winterthur, Switzerland.
Lemonnier J; Department of Medical Oncology, Hospital of Valais, Sion, Switzerland.
Hawle H; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.
Dietrich D; R&D, Unicancer, Paris, France.
Boven E; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.
Bonnefoi H; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland.

JAMA Oncol ; 9(10): 1381-1389, 2023 Oct 01.

Article en En | MEDLINE | ID: mdl-37561451

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google